ANRO (Alto Neuroscience) Other Long-Term Liabilities : $0.00 Mil (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Other Long-Term Liabilities?

Alto Neuroscience's other long-term liabilities for the quarter that ended in Sep. 2024 was $0.00 Mil.

Alto Neuroscience's quarterly other long-term liabilities declined from Mar. 2024 ($0.00 Mil) to Jun. 2024 ($0.00 Mil) but then stayed the same from Jun. 2024 ($0.00 Mil) to Sep. 2024 ($0.00 Mil).

Alto Neuroscience's annual other long-term liabilities increased from Dec. 2021 ($39.46 Mil) to Dec. 2022 ($74.24 Mil) and increased from Dec. 2022 ($74.24 Mil) to Dec. 2023 ($142.83 Mil).

Alto Neuroscience Other Long-Term Liabilities Historical Data

The historical data trend for Alto Neuroscience's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Other Long-Term Liabilities Chart

Alto Neuroscience Annual Data

Trend

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Alto Neuroscience Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Long-Term Liabilities	Get a 7-Day Free Trial					-	-	-	-	-

Alto Neuroscience Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Alto Neuroscience Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

369 South San Antonio Road, Los Altos, CA, USA, 94022

Website

https://www.altoneuroscience.com

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.